FASSAN, MATTEO
 Distribuzione geografica
Continente #
NA - Nord America 32.023
EU - Europa 3.085
AS - Asia 2.162
SA - Sud America 26
OC - Oceania 16
AF - Africa 6
Continente sconosciuto - Info sul continente non disponibili 6
Totale 37.324
Nazione #
US - Stati Uniti d'America 31.994
CN - Cina 1.640
IT - Italia 1.199
FI - Finlandia 553
SE - Svezia 428
GB - Regno Unito 310
DE - Germania 300
SG - Singapore 201
VN - Vietnam 112
UA - Ucraina 95
HK - Hong Kong 81
IN - India 70
IE - Irlanda 53
FR - Francia 43
CA - Canada 27
RU - Federazione Russa 20
NL - Olanda 17
BR - Brasile 15
AU - Australia 13
JP - Giappone 13
ES - Italia 12
RO - Romania 10
IR - Iran 9
PH - Filippine 9
AR - Argentina 8
GR - Grecia 8
TR - Turchia 8
CH - Svizzera 7
BE - Belgio 6
EU - Europa 6
AT - Austria 5
DK - Danimarca 5
KR - Corea 5
NZ - Nuova Zelanda 3
PK - Pakistan 3
SI - Slovenia 3
CO - Colombia 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
EG - Egitto 2
LK - Sri Lanka 2
MK - Macedonia 2
NO - Norvegia 2
PL - Polonia 2
RS - Serbia 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
CI - Costa d'Avorio 1
EC - Ecuador 1
GH - Ghana 1
KH - Cambogia 1
MY - Malesia 1
NP - Nepal 1
SA - Arabia Saudita 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
ZA - Sudafrica 1
Totale 37.324
Città #
Fairfield 6.333
Woodbridge 3.533
Houston 2.759
Chandler 2.663
Ashburn 2.618
Seattle 2.331
Cambridge 2.223
Wilmington 1.880
Ann Arbor 1.836
San Diego 719
Princeton 581
Beijing 528
Medford 493
Padova 402
Des Moines 376
Roxbury 324
Helsinki 296
Jacksonville 275
Nanjing 202
Boardman 152
New York 139
Singapore 122
Guangzhou 120
Dong Ket 106
Shenyang 73
Nanchang 72
Milan 70
London 68
Hebei 55
Jinan 50
Dublin 49
Kilburn 45
Rome 44
Ogden 43
Jiaxing 42
Changsha 40
Los Angeles 38
Norwalk 37
Kharkiv 33
Pune 33
Tianjin 32
Redwood City 28
Kunming 27
Lappeenranta 27
Shanghai 26
Hefei 25
Borås 20
Aprilia 19
Dearborn 19
Taizhou 19
Falls Church 18
Venice 18
Washington 17
Hangzhou 16
Hounslow 16
Ningbo 16
Zhengzhou 16
Fort Worth 15
Phoenix 15
Haikou 14
Chicago 13
Lanzhou 11
Prescot 11
Vicenza 11
Acton 10
Chiswick 10
Columbus 10
Hong Kong 10
Indiana 10
Paris 10
Rockville 10
Saint Louis 10
Salerno 10
Selvazzano Dentro 10
Taiyuan 10
Cluj-Napoca 9
Hanover 9
Legnaro 9
New Bedfont 9
Council Bluffs 8
Fuzhou 8
Genoa 8
Menlo Park 8
Naples 8
Tappahannock 8
Trento 8
Turin 8
Verona 8
Wuhan 8
Cagliari 7
Florence 7
Las Vegas 7
Pisa 7
Bologna 6
Detroit 6
Frankfurt am Main 6
Melbourne 6
Messina 6
Orange 6
Rovigo 6
Totale 32.548
Nome #
A pH-sensitive stearoyl-PEG-poly(methacryloyl sulfadimethoxine)-decorated liposome system for protein delivery: an application for bladder cancer treatment 181
Tumor-associated macrophages as major source of APRIL in gastric MALT lymphoma. 166
Class 1, 2 and 3 BRAF mutated metastatic colorectal cancer: a detailed clinical, pathological and molecular characterization 165
Genetic, epigenetic and immunologic profiling of MMR-deficient relapsed glioblastoma 163
Detection of genetic alterations in cfDNA as a possible strategy to monitor the neoplastic progression of Barrett's esophagus 160
Epithelial CD80 promotes immune surveillance of colonic preneoplastic lesions and its expression is increased by oxidative stress through STAT3 in colon cancer cells 159
Letter to Editor: Reply to R.T. Casey (Semin Oncol. 2018 Jun;45(3):151-155) 155
Mitostatin is down-regulated in human prostate cancer and suppresses the invasive phenotype of prostate cancer cells. 154
PDCD4 nuclear loss inversely correlates with miR-21 levels in colon carcinogenesis. 152
A triple rare E709K and L833V/H835L EGFR mutation responsive to an irreversible pan-HER inhibitor: A case report of lung adenocarcinoma treated with afatinib 151
Insulin promotes HER2 signaling activation during Barrett's Esophagus carcinogenesis 150
Tryptophan metabolism along the kynurenine and serotonin pathways reveals substantial differences in colon and rectal cancer 150
Autoimmune gastritis: histology phenotype and OLGA staging. 149
The SWI/SNF complex is a mechanoregulated inhibitor of YAP and TAZ 149
Claudin-18 expression in oesophagogastric adenocarcinomas: a tissue microarray study of 523 molecularly profiled cases 146
SCCA1 is associated to poor prognosis in esophageal cancer through immune surveillance impairment and reduced chemosensitivity 145
Epithelial–mesenchymal transition in malignant mesothelioma 144
Extra-nodal extension of sentinel lymph node metastasis is a marker of poor prognosis in breast cancer patients: A systematic review and an exploratory meta-analysis 144
166P: Non-small cell lung cancer (NSCLC) patients with rare or complex epidermal growth factor receptor (EGFR) mutations: A single institution series 143
Molecular characterization of “sessile serrated” adenoma to carcinoma transition in six early colorectal cancers 140
The role of immune microenvironment in small-cell lung cancer: Distribution of PD-L1 expression and prognostic role of FOXP3-positive tumour infiltrating lymphocytes 139
Transcriptional addiction in cancer cells is mediated by YAP/TAZ through BRD4 137
Role of proton pump inhibitor on esophageal carcinogenesis and pancreatic acinar cell metaplasia development: an experimental in vivo study. 135
The PDCD4/miR-21 pathway in medullary thyroid carcinoma. 134
A coordinate deregulation of microRNAs expressed in mucosa adjacent to tumor predicts relapse after resection in localized colon cancer 132
Young investigator challenge: MicroRNA-21/MicroRNA-126 profiling as a novel tool for the diagnosis of malignant mesothelioma in pleural effusion cytology 131
Human papillomavirus infection is not involved in esophageal verrucous carcinoma 131
BRAF p.V600E-specific immunohistochemical assessment in colorectal cancer endoscopy biopsies is consistent with the mutational profiling 130
A Case of Carcinosarcoma of the Gastroesophageal Junction With Neuroendocrine and Chondroid Differentiation 130
HER2 status in gastroesophageal cancer: a tissue microarray study of 1040 cases. 128
LONG-NONCODING RNAs in gastroesophageal cancers 128
Extraskeletal Myxoid Chondrosarcoma of the Foot Clinically Mimicking Plantar Fibromatosis 128
Operative link for gastritis assessment vs operative link on intestinal metaplasia assessment 126
An overview on clinical, pathological and molecular features of lung metastases from colorectal cancer 125
Aberrant expression of CD10 and BCL6 in mantle cell lymphoma 124
Adherence to WCRF/AICR lifestyle recommendations for cancer prevention and the risk of Barrett’s esophagus onset and evolution to esophageal adenocarcinoma: results from a pilot study in a high-risk population 123
CK7 and consensus molecular subtypes as major prognosticators in V600E BRAF mutated metastatic colorectal cancer 123
The immune receptor CD300e negatively regulates T cell activation by impairing the STAT1-dependent antigen presentation 121
18F-FDG PET findings and GLUT-1 expression in IPMNs of the pancreas. 119
Autoimmune gastritis: Pathologist's viewpoint 118
Clinical features and treatment outcome of non-small cell lung cancer (NSCLC) patients with uncommon or complex epidermal growth factor receptor (EGFR) mutations 118
Immunotherapy in Gastrointestinal Cancers 118
"Double Trouble" or an Amplification of the Triploidy Phenotype? 118
Serum miR-125b is a non-invasive predictive biomarker of the pre-operative chemoradiotherapy responsiveness in patients with rectal adenocarcinoma 117
miR-194 as predictive biomarker of responsiveness to neoadjuvant chemoradiotherapy in patients with locally advanced rectal adenocarcinoma 117
Prognostic role of BAP-1 and PBRM-1 expression in intrahepatic cholangiocarcinoma 117
Inflammatory myofibroblastic tumor as adverse outcome of eosinophilic esophagitis. 115
Noncoding RNAs as drivers of the phenotypic plasticity of oesophageal mucosa 115
Efficacy and Safety of Immune Checkpoint Inhibitors in Patients with Microsatellite Instability-High End-Stage Cancers and Poor Performance Status Related to High Disease Burden 115
Liver steatosis in children with chronic hepatitis C 114
In vivo molecular imaging of HER2 expression in a rat model of Barrett's esophagus adenocarcinoma 114
Clear cell dysplasia in a sessile serrated adenoma 114
Alternative lengthening of telomeres (ALT) influences survival in soft tissue sarcomas: a systematic review with meta-analysis 114
Thyroid-like follicular carcinoma of the kidney: The mutational profiling reveals a BRAF wild type status 114
Inflammation and pancreatic cancer: molecular and functional interactions between S100A8, S100A9, NT-S100A8 and TGFβ1 113
Programmed cell death 4 nuclear loss and miR-21 or activated Akt overexpression in esophageal squamous cell carcinogenesis. 112
miR-224 Is Significantly Upregulated and Targets Caspase-3 and Caspase-7 During Colorectal Carcinogenesis 112
Programmed cell death 4 protein in esophageal cancer 111
Isolated Tumor Cells in Regional Lymph Nodes as Relapse Predictors in Stage I and II Colorectal Cancer 111
HER-2/neu expression is consistent in primary and metastatic lung adenocarcinoma 111
Aurora kinase A in Barrett's carcinogenesis. 111
MiR-122 Targets SerpinB3 and Is Involved in Sorafenib Resistance in Hepatocellular Carcinoma 111
Microfluidic chip technology applied to fine-needle aspiration cytology samples for IGH clonality assessment 111
MIR21 drives resistance to Heat Shock Protein 90 inhibition in cholangiocarcinoma 110
Benefit from anti-EGFRs in RAS and BRAF wild-type metastatic transverse colon cancer: a clinical and molecular proof of concept study 110
Concurrent pheochromocytoma and cortical carcinoma of the adrenal gland 109
HP-NAP inhibits the growth of bladder cancer in mice by activating a cytotoxic Th1 response. 109
Gastric Linitis Plastica and Peritoneal Carcinomatosis as First Manifestations of Occult Breast Carcinoma: A Case Report and Literature Review 109
Whole-genome landscape of pancreatic neuroendocrine tumours 108
Programmed cell death-ligand 1 (PD-L1) overexpression in ampulla of Vater carcinoma and its pre-invasive lesions 108
Correction to: Effects of immune suppression for transplantation on inflammatory colorectal cancer progression (Oncogenesis, (2018), 7, 6, (46), 10.1038/s41389-018-0055-5) 108
Early signet ring cell carcinoma arising from colonic adenoma: The molecular profiling supports the adenoma-carcinoma sequence 108
Immunotherapy in Gastrointestinal Cancers 107
Extranodal Extension of Nodal Metastases Is a Poor Prognostic Indicator in Gastric Cancer: a Systematic Review and Meta-analysis 106
The Disabled homolog 2 controls pro-metastatic activity of tumor-associated macrophages 106
Anterior Gradient 2 Overexpression in Lung Adenocarcinoma 105
Assessment of intratumor immune-microenvironment in colorectal cancers with extranodal extension of nodal metastases 105
The Role of Helicobacter pylori in the Spectrum of Barrett's Carcinogenesis 104
MicroRNA Expression Profiling in the Histological Subtypes of Barrett's Metaplasia. 104
Liquid biopsy as a novel tool to monitor the carcinogenesis of Barrett's esophagus 104
Let-7c down-regulation in Helicobacter pylori-related gastric carcinogenesis 104
Concomitant IDH-wildtype glioblastoma and IDH1-mutant anaplastic astrocytoma in a patient with constitutional mismatch repair deficiency syndrome 104
Prevalence of ALK gene alterations among the spectrum of plexiform spitzoid lesions 104
Reprogramming normal cells into tumour precursors requires ECM stiffness and oncogene-mediated changes of cell mechanical properties 104
Prognostic impact of immune-microenvironment in colorectal liver metastases resected after triplets plus a biologic agent: A pooled analysis of five prospective trials 104
Adenosquamous carcinoma of the papilla of Vater: A phenotypic heterogeneity characterized by a common molecular landscape 104
The original sin of oesophageal mucosa. 103
Profiling of Expression of Human Papillomavirus-Related Cancer miRNAs in Penile Squamous Cell Carcinomas 103
Fine-needle cytology of cutaneous juvenile xanthogranuloma and langerhans cell histiocytosis. 102
HP-NAP new therapy for bladder cancer: numquam periculum sine periculo vincitur 102
Anterior gradient 2 profiling in Barrett columnar epithelia and adenocarcinoma. 102
Dynamic changes of live/apoptotic circulating tumour cells as predictive marker of response to Sunitinib in metastatic renal cancer 102
Radiological-Pathological Comparison in a Case of Conjoined Gnatho-Thoracopagus Twins 102
Congenital pulmonary airway malformation (CPAM) [congenital cystic adenomatoid malformation] associated with tracheoesophageal fistula and agensesis of the corpus callosum. 102
Squamous Cellular Carcinoma Antigen Serum Determination as a Biomarker of Barrett Esophagus and Esophageal Cancer: A Phase III Study 102
Decellularized colorectal cancer matrix as bioactive microenvironment for in vitro 3D cancer research 102
OLGA Gastritis Staging for the Prediction of Gastric Cancer Risk: A Long-term Follow-up Study of 7436 Patients 102
Adenosquamous gallbladder carcinoma: Multigene hotspot mutational profiling reveals a monoclonal origin of the two components 101
Helicobacter pylori affects the antigen presentation activity of macrophages modulating the expression of the immune receptor CD300E through miR-4270 101
The HER2-miR125a5p/miR125b loop in gastric and esophageal carcinogenesis. 100
Totale 12.121
Categoria #
all - tutte 152.302
article - articoli 147.782
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 305
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.342
Totale 301.731


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20192.242 0 0 0 0 0 0 0 0 0 0 1.148 1.094
2019/20208.571 899 375 208 1.134 829 599 842 934 1.088 737 533 393
2020/20216.802 304 574 271 420 231 442 600 641 808 943 878 690
2021/20227.920 334 811 936 415 352 563 646 730 562 221 664 1.686
2022/20235.295 1.094 594 130 702 716 578 47 360 656 98 249 71
2023/20242.934 131 458 338 270 244 408 347 180 190 110 258 0
Totale 38.069